Purpose of ex vivo lesion studies
Ex vivo lesion studies in radiofrequency (RF) ablation are designed to characterize how RF energy interacts with biological tissues under controlled conditions, before techniques and devices are applied in vivo. By using standardized tissue models and tightly regulated temperature and time parameters, investigators can quantify lesion dimensions, assess reproducibility, and identify thresholds for stable lesion formation. For example, ex vivo testing of a novel multitined expandable electrode used tissue samples equilibrated in a 37 °C water bath and applied heating cycles ranging from 60 to 240 seconds at 65–90 °C to estimate lesion size and shape based on visible coagulation.
A central purpose of these studies is to define the relationship between RF system settings and the resulting zone of coagulation. The RF-induced lesion is governed by factors such as current density, duration of heating, temperature at the electrode–tissue interface, and the size of the active electrode surface. Ex vivo models allow systematic variation of these parameters to determine how they influence lesion geometry without the confounding effects of perfusion, patient movement, or anatomic variability. This provides a biophysical foundation for later protocol development in clinical practice.
Ex vivo experiments are also used to validate new electrode designs and configurations. In the development of the multitined directional electrode, more than 100 lesions were created in muscle and organ tissue to confirm that the device produced a large-volume, directional lesion with consistent geometry and without anomalous heating phenomena such as boiling, charring, or cavitation. Similarly, comparative ex vivo work has been performed to evaluate cooled RF, protruding electrode systems, and conventional monopolar probes, with lesion volumes calculated from measured longitudinal, transverse, and depth dimensions using ellipsoid volume equations.
Another key role of ex vivo lesion studies is to provide reference data that can be correlated with in vivo thermal mapping. In the case of the multitined electrode, ex vivo visible coagulation and thermal imaging established a predictable, directional lesion profile and a mature lesion threshold at approximately 75 °C for 80 seconds. These findings were then compared with in vivo temperature measurements during lumbar medial branch neurotomy, where neurodestructive temperatures were achieved at the target while collateral structures remained near baseline temperature, demonstrating consistency between bench and in vivo performance.
Finally, ex vivo models are used to explore methods for enhancing lesion size and to test strategies that may not yet be suitable for immediate clinical use. Consensus guidance notes that multiple methods to increase lesion size—such as increasing cannula diameter, active tip length, lesion time, or using internally cooled electrodes—have been studied in both in vivo and ex vivo settings. Ex vivo work provides the initial safety and performance data necessary to justify subsequent clinical evaluation of these RF techniques.
Tissue response and lesion geometry
Tissue response to RF energy is fundamentally governed by resistive heating around the active electrode. Biological tissue exhibits impedance to current flow, and when low-energy, high-frequency current (approximately 100–500 kHz) is applied, electromagnetic energy is converted into heat through rapid oscillation of charged and dipolar molecules, particularly water. A tissue temperature of about 45 °C initiates microscopic cellular changes consistent with neuroablation, whereas temperatures above 60 °C are associated with soft tissue coagulation, and temperatures exceeding 100 °C can cause boiling, steam formation, and cavitation with undesired tissue damage.
The spatial distribution of temperature around the electrode determines lesion geometry. Tissue heating is directly related to current density and inversely related to the fourth power of the radius from the electrode, leading to a rapid drop in temperature with increasing distance from the active surface. In conventional monopolar RF, most thermal coagulation extends radially around the exposed shaft of the electrode, with minimal propagation distal to the tip. This produces a prolate ellipsoid lesion, often likened to an American football, centered on the active tip. The lesion propagates until rising resistance in coagulated tissue leads to impedance roll-off, typically after about 90 seconds at 80 °C, beyond which additional time or temperature does not significantly increase lesion size.
Ex vivo thermographic studies further refine understanding of lesion evolution. In the multitined electrode model, surface thermal imaging demonstrated smooth progression from initial coagulation around distal tine tips to consolidation toward the central cannula, with thermally balanced isotherms and absence of hot spots or asymmetric activation. The mature lesion exhibited a 55 °C isotherm that closely matched the visible coagulation boundary, supporting the correlation between macroscopic lesion appearance and tissue temperatures above approximately 55 °C, as also noted in comparative ex vivo work on cooled and protruding electrode systems.
Different RF systems generate distinct lesion geometries. Ex vivo comparison of cooled RF, protruding electrode (“V”-shaped) systems, and monopolar probes showed that cooled RF produces quasi-spherical lesion propagation as time increases, due to active cooling of the tip that prevents rapid coagulation immediately adjacent to the electrode and allows more efficient heat transfer distally. In contrast, monopolar and protruding electrode lesions tend to propagate predominantly in two dimensions (transverse and depth), with slower longitudinal growth, and lesion size is strongly dependent on active tip length and diameter. These geometric characteristics are critical when targeting small, variably located sensory nerves, where the effective radius of the lesion and its orientation relative to the nerve determine the extent of neurotomy.
Ex vivo studies also highlight the influence of baseline tissue conditions on lesion geometry. Consensus guidance notes that ex vivo models with lower baseline tissue temperatures can underestimate in vivo lesion size, because additional energy is required to reach the same ablation zone. Furthermore, the presence of bone can significantly alter lesion geometry, with the maximal effective radius approximately doubling against bone compared with a muscle-only model. These observations underscore that lesion geometry is not solely a function of electrode design and generator settings, but also of local tissue composition and boundary conditions.
Comparison of electrode configurations
Conventional monopolar RF electrodes consist of an insulated cannula with a distal active tip, creating a lesion whose size is limited by the small effective radius of coagulation. The radius of a monopolar RF lesion is typically on the order of one to two times the diameter of the electrode, placing an upper bound on lesion width. Given the small size and variable location of sensory nerves, consistent denervation with monopolar probes often requires electrode placement within 1–2 mm of the target nerve. This technical constraint has motivated the development of alternative configurations aimed at enlarging and reshaping the ablation zone.
One strategy is to modify the active tip geometry and gauge. Ex vivo comparisons of monopolar RF using 16, 18, and 20 gauge probes demonstrated that increasing tip diameter significantly increases lesion volume, with a 16 g monopolar probe producing a mean lesion volume 21% larger than that obtained with the largest protruding electrode needle (18 g) in the same study. The same work confirmed that lesion length in monopolar RF is directly proportional to active tip length; increasing tip length by 5 mm increases lesion length by approximately 5 mm, with corresponding effects on volume. However, larger monopolar lesions remain constrained by their ellipsoidal shape and limited distal extension.
Cooled RF systems represent another configuration, in which an internal perfusate cools the active tip, acting as a heat sink that removes heat closest to the electrode. This reduces overheating at the electrode–tissue interface, allowing greater current deposition and larger lesions that extend more distally beyond the cannula tip. In ex vivo comparison, cooled RF using a 17 g probe with a 4 mm active tip at 60 °C for 150 seconds produced lesions significantly larger than those generated by protruding electrode systems with 18 or 20 g, 10 mm tips at 80 °C for 150 seconds. Despite the shorter active tip, cooled RF achieved a lesion volume much larger than would be expected for a monopolar probe of equivalent tip length, and lesion propagation was quasi-spherical in three dimensions.
Protruding electrode systems combine an active cannula and a protruding inner electrode to create a “V”-shaped zone in which the lesion develops, producing a larger ablation volume than a monopolar probe with an introducer of equivalent gauge and length. Thermographic imaging in ex vivo models showed that during the pre-warming period, these systems may initially generate heat at two points that subsequently coalesce, resembling a bipolar pattern, with most of the lesion forming early in the cycle. Lesion growth thereafter is slower and predominantly in the transverse and depth dimensions, with minimal additional longitudinal extension.
Multitined expandable electrodes offer a different approach by increasing the functional electrode surface area through deployable tines that diffuse RF current density within the target tissue. Ex vivo visible coagulation studies with this design demonstrated a highly reproducible, elongate spheroid lesion offset from the central cannula toward the tines, with an average volume of approximately 467 ± 71 mm³ and minimal variance beyond a threshold of 75 °C for 80 seconds. Thermal mapping confirmed symmetrical tine activation and directional lesion formation without hot spots. Compared with strategies such as multiple monopolar placements, bipolar RF, simultaneous parallel lesions, fluid injection, or internally cooled probes, the multitined configuration was developed to provide an optimally shaped 8–10 mm diameter lesion, offset from the cannula axis, while maintaining compatibility with existing RF generators.
Relevance to clinical procedures
Ex vivo lesion data directly inform the technical goals of clinical RF neurotomy. High-grade pain relief after RF thermal neurotomy depends on thorough destruction of the targeted nociceptive pathway, and the duration of relief correlates with the length of nerve coagulated. Heuristically, a 10 mm interruption in the pain-transmitting pathway is considered desirable. Ex vivo studies that define lesion diameters and lengths for different electrode configurations and settings therefore provide a basis for selecting techniques capable of achieving this extent of neurotomy in vivo.
The technical limitations of conventional monopolar RF, highlighted in both experimental and clinical literature, underscore the importance of lesion geometry. Because the effective radius of a monopolar lesion is small, and the lesion assumes a prolate ellipsoid shape around the active tip, successful neurotomy requires the active tip to be placed parallel and adjacent to the target nerve. Any deviation from parallel alignment reduces the length of nerve coagulated, with perpendicular placement resulting in a point lesion and technical failure. Cadaveric studies have demonstrated substantial anatomic variability in spinal innervation, further complicating consistent parallel placement. Ex vivo lesion data thus support the clinical rationale for devices and techniques that enlarge and direct the lesion to better accommodate anatomic variation.
The multitined directional electrode provides a clear example of translation from ex vivo findings to clinical application. Ex vivo visible coagulation and thermal imaging established that this device produced a consistent, directional lesion with an optimally shaped 10 mm footprint and no anomalous heating. In vivo thermal mapping during lumbar medial branch neurotomy then demonstrated a thermal profile consistent with ex vivo results: neurodestructive temperatures were achieved at the target medial branch and mammillary process, while adjacent spinal nerves and lateral branches remained near baseline temperature. These data supported the introduction of the device into clinical practice for selected spinal targets, with early experience suggesting technically effective medial branch neurotomy using a “down-the-beam” approach and medial tine deployment along the superior articular process.
Ex vivo comparisons of cooled, protruding, and monopolar RF systems are also clinically relevant, particularly for targets such as sacral lateral branches where broad coverage is desired. In sacroiliac joint interventions, for example, strip lesion techniques using multiple conventional probes or specialized multilesion devices have been developed to capture a high proportion of lateral branches over a 50 mm or greater segment. Cooled RF techniques that generate larger, quasi-spherical lesions have been modeled in cadaveric periforaminal approaches, with lesion sites planned relative to sacral foramina to maximize branch capture. The ex vivo evidence that cooled RF produces larger lesions than protruding or monopolar systems at comparable or lower temperatures informs these clinical strategies.
Consensus guidance on RF interventions integrates ex vivo findings into practical recommendations for enhancing lesion size in clinical practice. Techniques such as increasing set temperature (within safe limits below the electrode interface disruption temperature), increasing cannula diameter, enlarging active tip length, and prolonging lesion time have all been shown to increase lesion dimensions in experimental models. For instance, increasing cannula diameter from 22 to 16 gauge at 80 °C for 2 minutes increases average lesion width by 58–65%, corresponding to a 3–4 mm larger lesion, and extending lesion time from 1 to 3 minutes increases lesion size by 23–32%. These quantitative relationships, derived in part from ex vivo work, guide parameter selection when tailoring RF procedures to specific anatomical targets.
Limits of experimental models
Despite their value, ex vivo RF models have important limitations that must be recognized when extrapolating to clinical practice. One key issue is the difference in tissue properties between experimental media and living tissue. Consensus guidance notes substantial differences between fluid egg white and solid animal tissue: egg white heats faster than muscle, but lesions in egg white typically underestimate lesion size and are not consistently reproducible. This underscores that results obtained in simplified media may not accurately reflect lesion behavior in more complex, heterogeneous tissues.
Baseline tissue temperature is another critical factor. Ex vivo models often start at lower temperatures than in vivo tissues, which are near physiological levels. As a result, ex vivo RF lesions can underestimate in vivo lesion size because higher energy deposition is required to reach the same ablation zone from a lower starting temperature. Studies using tissue equilibrated at 37 °C, such as the multitined electrode experiments in muscle and liver, attempt to mitigate this limitation, but they still lack the dynamic perfusion and metabolic activity present in living organisms.
Anatomic context also differs markedly between ex vivo and in vivo conditions. The presence of bone, for example, can significantly alter lesion geometry, with the maximal effective radius approximately doubling against bone compared with a muscle-only model. Ex vivo studies that do not incorporate realistic bone–soft tissue interfaces may therefore misrepresent lesion spread near osseous structures. Similarly, the heterogeneous composition of clinical targets—such as mixed fat, muscle, ligament, and joint capsule—can lead to asymmetric lesion propagation that is not captured in homogeneous ex vivo specimens like chicken breast or uniform muscle blocks.
Dynamic physiological processes further limit the direct applicability of ex vivo data. In vivo, blood flow and tissue perfusion act as heat sinks, redistributing thermal energy and potentially constraining lesion growth, whereas ex vivo tissues lack this convective cooling. The consensus document emphasizes that ex vivo models do not necessarily simulate in vivo conditions and that careful attention must be paid to the medium and baseline conditions used in testing. Moreover, ex vivo studies typically do not account for patient-specific factors such as prior surgery, fibrosis, or variable tissue impedance, all of which can influence lesion formation. These limitations highlight the need to interpret ex vivo findings as approximations that require validation through in vivo thermal mapping and clinical outcome studies.
Finally, some experimental configurations are inherently difficult to translate directly to clinical anatomy. For example, strategies such as simultaneous parallel lesions or complex bipolar arrangements may produce well-defined lesion geometries in ex vivo models, but their in vivo effects are likely to be more variable due to challenges in reproducing precise inter-cannula spacing and orientation relative to target nerves. Similarly, internally cooled probes can generate large spherical lesions ex vivo, but the risk of collateral tissue injury in vivo must be weighed carefully, particularly in regions with closely adjacent neural or vascular structures. These considerations reinforce that ex vivo models are tools for understanding biophysics and device performance, not substitutes for clinical judgment.
Translating lab data to practice
Translating ex vivo RF data into operative technique begins with a clear understanding of the biophysical determinants of lesion size. The simplified bio-heat framework conceptualizes coagulation necrosis as the balance between heat generated and heat lost through local tissue interactions. In a thermal RF system, three primary factors—distance from the active tip, RF current density, and duration of current application—govern heat generation and lesion size. Ex vivo studies that quantify how changes in cannula gauge, active tip length, set temperature, and lesion time affect lesion dimensions provide clinicians with practical levers to adjust when planning procedures for specific targets.
For conventional monopolar RF, ex vivo and theoretical work show that lesion radius is constrained to approximately one to two times the electrode diameter and that most coagulation occurs circumferentially around the shaft rather than distally. Clinically, this translates into the requirement for meticulous electrode placement parallel and adjacent to the target nerve to achieve an adequate length of neurotomy. Where such placement is difficult or anatomic variability is high, ex vivo evidence supporting larger or directional lesions with alternative configurations—such as cooled RF, protruding electrodes, or multitined devices—can guide selection of techniques that offer a wider margin for capturing the nociceptive pathway.
The multitined expandable electrode illustrates a structured pathway from bench to bedside. Ex vivo visible coagulation and thermal mapping established that a heating protocol of approximately 75 °C for 80 seconds produced a mature, reproducible directional lesion of about 10 mm in diameter without anomalous heating. In vivo thermal mapping during lumbar medial branch neurotomy then confirmed that this protocol achieved neurodestructive temperatures at the medial branch and mammillary process while maintaining near-physiologic temperatures at adjacent spinal nerves and lateral branches. These concordant data supported the adoption of a “down-the-beam” fluoroscopic approach with medial tine deployment along the superior articular process as a rational technique for lumbar medial branch neurotomy using this device.
More broadly, consensus recommendations on methods to enhance lesion size—such as increasing cannula diameter, extending lesion time, and using internally cooled electrodes—are grounded in experimental work that includes ex vivo models. Increasing cannula diameter from 22 to 16 gauge at 80 °C for 2 minutes has been shown to increase lesion width by 58–65%, and extending lesion time from 1 to 3 minutes increases lesion size by up to one-third. Internally cooled electrodes, by reducing overheating at the interface and shifting maximal heating to tissue approximately 2.5 mm from the tip, generate larger distal lesions than standard electrodes. When applying these findings in practice, clinicians must balance the desire for larger lesions to accommodate anatomic variability against the risk of collateral injury, particularly near critical neural structures.
Effective translation of lab data to the operating room also requires integrating ex vivo insights with imaging and neurophysiologic guidance. While ex vivo models define expected lesion geometry for a given configuration and protocol, intra-procedural fluoroscopy and neurostimulation remain essential for confirming safe and effective electrode placement relative to patient-specific anatomy. As more clinical outcome data accumulate for techniques informed by ex vivo studies—such as cooled RF for sacral lateral branches or multitined electrodes for medial branch neurotomy—these results can be fed back into experimental design, refining models to better reflect clinically relevant scenarios. This iterative process strengthens the bridge from laboratory biophysics to reproducible, target-specific RF interventions in the operating room.
Sources (Bibliography)
- Consensus practice guidelines on interventions.
- Wright RE, Allen, Craft, Holley. Radiofrequency Ablation Using a Novel Multitined Expandable Electrode (Full Text with Ex Vivo and In Vivo Mapping).
- Vallejo R, Benyamin R, Tilley DM, Kelley CA, Cedeno DL. Ex Vivo Comparison of Cooled, Protruding, and Monopolar RF Lesions. Pain Physician, 2017.
- Loh et al. Sacroiliac Joint Diagnostic Block and Radiofrequency Ablation Techniques.